[Code of Federal Regulations]
[Title 21, Volume 1]
[Revised as of April 1, 2001]
From the U.S. Government Printing Office via GPO Access
[CITE: 21CFR5.70]

[Page 57-58]
 
                        TITLE 21--FOOD AND DRUGS
 
CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN 
                                SERVICES
 
PART 5--DELEGATIONS OF AUTHORITY AND ORGANIZATION--Table of Contents
 
Subpart B--Redelegations of Authority from the Commissioner of Food and 
                                  Drugs
 
Sec. 5.70  Issuance of notice implementing the provisions of the Drug Amendments of 1962.

    The Director, Deputy Center Director for Review Management, and 
Deputy Director, Center Director for Pharmaceutical Science, Center for 
Drug Evaluation and Research (CDER), are authorized to issue notices and 
amendments thereto implementing section 107(c)(3) of the Drug Amendments 
of 1962 (Pub. L. 87-781) by announcing new or revised efficacy findings 
on human drugs that are or were subject to the

[[Page 58]]

provisions of section 505 of the Federal Food, Drug, and Cosmetic Act.

[62 FR 2556, Jan. 17, 1997, as amended at 64 FR 398, Jan. 5, 1999]